142 related articles for article (PubMed ID: 19203467)
1. Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine: A comparison with vigabatrin.
Todd KG; Baker GB
J Pharm Pharm Sci; 2008 May; 11(2):14s-21s. PubMed ID: 19203467
[TBL] [Abstract][Full Text] [Related]
2. GABA-elevating effects of the antidepressant/antipanic drug phenelzine in brain: effects of pretreatment with tranylcypromine, (-)-deprenyl and clorgyline.
Todd KG; Baker GB
J Affect Disord; 1995 Dec; 35(3):125-9. PubMed ID: 8749840
[TBL] [Abstract][Full Text] [Related]
3. Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition.
MacKenzie EM; Grant SL; Baker GB; Wood PL
Neurochem Res; 2008 Mar; 33(3):430-6. PubMed ID: 17768678
[TBL] [Abstract][Full Text] [Related]
4. Effects of the MAO inhibitor phenelzine on glutamine and GABA concentrations in rat brain.
Paslawski TM; Sloley BD; Baker GB
Prog Brain Res; 1995; 106():181-6. PubMed ID: 8584653
[TBL] [Abstract][Full Text] [Related]
5. Effects of the antidepressant/antipanic drug phenelzine on alanine and alanine transaminase in rat brain.
Tanay VA; Parent MB; Wong JT; Paslawski T; Martin IL; Baker GB
Cell Mol Neurobiol; 2001 Aug; 21(4):325-39. PubMed ID: 11775064
[TBL] [Abstract][Full Text] [Related]
6. Time-dependent changes in brain monoamine oxidase activity and in brain levels of monoamines and amino acids following acute administration of the antidepressant/antipanic drug phenelzine.
Parent MB; Habib MK; Baker GB
Biochem Pharmacol; 2000 May; 59(10):1253-63. PubMed ID: 10736426
[TBL] [Abstract][Full Text] [Related]
7. Chronic administration of the antidepressant phenelzine and its N-acetyl analogue: effects on GABAergic function.
McKenna KF; McManus DJ; Baker GB; Coutts RT
J Neural Transm Suppl; 1994; 41():115-22. PubMed ID: 7931216
[TBL] [Abstract][Full Text] [Related]
8. Effects of the antidepressant/antipanic drug phenelzine and its putative metabolite phenylethylidenehydrazine on extracellular gamma-aminobutyric acid levels in the striatum.
Parent MB; Master S; Kashlub S; Baker GB
Biochem Pharmacol; 2002 Jan; 63(1):57-64. PubMed ID: 11754874
[TBL] [Abstract][Full Text] [Related]
9. Effects of two substituted hydrazine monoamine oxidase (MAO) inhibitors on neurotransmitter amines, gamma-aminobutyric acid, and alanine in rat brain.
Yamada N; Takahashi S; Todd KG; Baker GB; Paetsch PR
J Pharm Sci; 1993 Sep; 82(9):934-7. PubMed ID: 7901387
[TBL] [Abstract][Full Text] [Related]
10. Effects of the antidepressant/antipanic drug phenelzine on GABA concentrations and GABA-transaminase activity in rat brain.
McManus DJ; Baker GB; Martin IL; Greenshaw AJ; McKenna KF
Biochem Pharmacol; 1992 Jun; 43(11):2486-9. PubMed ID: 1610412
[TBL] [Abstract][Full Text] [Related]
11. Recent studies on the MAO inhibitor phenelzine and its possible metabolites.
McKenna KF; Baker GB; Coutts RT; Rauw G; Mozayani A; Danielson TJ
J Neural Transm Suppl; 1990; 32():113-8. PubMed ID: 1982447
[TBL] [Abstract][Full Text] [Related]
12. Task-dependent effects of the antidepressant/antipanic drug phenelzine on memory.
Parent MB; Habib MK; Baker GB
Psychopharmacology (Berl); 1999 Mar; 142(3):280-8. PubMed ID: 10208320
[TBL] [Abstract][Full Text] [Related]
13. Elevation of rat brain tyrosine levels by phenelzine is mediated by its active metabolite β-phenylethylidenehydrazine.
Matveychuk D; Nunes E; Ullah N; Aldawsari FS; Velázquez-Martínez CA; Baker GB
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():67-73. PubMed ID: 24607770
[TBL] [Abstract][Full Text] [Related]
14. The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).
Benson CA; Wong G; Tenorio G; Baker GB; Kerr BJ
Behav Brain Res; 2013 Sep; 252():302-11. PubMed ID: 23777648
[TBL] [Abstract][Full Text] [Related]
15. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
Alemany R; Olmos G; García-Sevilla JA
Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of the effects of oxidative stress by the MAO-inhibiting antidepressant and carbonyl scavenger phenelzine.
Baker G; Matveychuk D; MacKenzie EM; Holt A; Wang Y; Kar S
Chem Biol Interact; 2019 May; 304():139-147. PubMed ID: 30857888
[TBL] [Abstract][Full Text] [Related]
17. The antidepressant phenelzine enhances memory in the double Y-maze and increases GABA levels in the hippocampus and frontal cortex of rats.
Simpson SM; Hickey AJ; Baker GB; Reynolds JN; Beninger RJ
Pharmacol Biochem Behav; 2012 Jul; 102(1):109-17. PubMed ID: 22503968
[TBL] [Abstract][Full Text] [Related]
18. Comparison of neurochemical effects of the monoamine oxidase inhibitors phenelzine, moclobemide and brofaromine in the rat after short- and long-term administration.
Urichuk LJ; Allison K; Holt A; Greenshaw AJ; Baker GB
J Affect Disord; 2000 May; 58(2):135-44. PubMed ID: 10781703
[TBL] [Abstract][Full Text] [Related]
19. The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA.
Paslawski T; Treit D; Baker GB; George M; Coutts RT
Psychopharmacology (Berl); 1996 Sep; 127(1):19-24. PubMed ID: 8880939
[TBL] [Abstract][Full Text] [Related]
20. The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE).
Musgrave T; Benson C; Wong G; Browne I; Tenorio G; Rauw G; Baker GB; Kerr BJ
Brain Behav Immun; 2011 Nov; 25(8):1677-88. PubMed ID: 21723939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]